Nykode Therapeutics
NYKD.OL
#9012
Rank
NZ$0.11 B
Marketcap
$0.36
Share price
-44.08%
Change (1 day)
-86.78%
Change (1 year)

P/S ratio for Nykode Therapeutics (NYKD.OL)

P/S ratio as of November 2024 (TTM): 11.6

According to Nykode Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.4691. At the end of 2024 the company had a P/S ratio of 76.1.

P/S ratio history for Nykode Therapeutics from 2021 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202476.142.63%
202353.3-54.41%
202211749.66%
202178.2